A Phase 1b, 2-part, placebo-controlled study to evaluate the efficacy, safety, and PK of PF-07054894 in participants with mild to severe UC.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501047-32-00

Acronym

C4151002

Enrollment

Registered

2023-03-14

Start date

2023-05-30

Completion date

2025-11-05

Last updated

2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ULCERATIVE COLITIS

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026